Botulinum toxin: Basic science and clinical uses in otolaryngology

被引:124
作者
Blitzer, A
Sulica, L
机构
[1] Beth Israel Deaconess Med Ctr, Dept Otolaryngol Head & Neck Surg, Phillips Ambulatory Care Ctr, New York, NY 10003 USA
[2] St Lukes Roosevelt Hosp, New York Ctr Voice & Swallowing Disorders, New York, NY USA
关键词
botulinum toxin; dystonia; spasmodic dysphonia; laryngeal disease; oromandibular dystonia; cricopharyngeal spasm; blepharospasm; facial lines; migraine; Frey syndrome; Facial synkinesis; hemifacial spasm;
D O I
10.1097/00005537-200102000-00006
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The role of botulinum toxin as a therapeutic agent is expanding rapidly in otolaryngology. Botulinum toxin is a protease that blocks the release of acetylcholine from nerve terminals. Its effects are transient and nondestructive, and largely limited to the area in which it is administered. These effects are also graded according to dose, allowing for individualized treatment of patients and disorders. Botulinum toxin has been used primarily to treat disorders of excessive or inappropriate muscle contraction. In the field of otolaryngology, these include spasmodic dysphonia, oromandibular dystonia, and blepharospasm; vocal tics and stuttering; cricopharyngeal achalasia; various tremors and tics; hemifacial spasm; temporomandibular joint disorders; and a number of cosmetic applications. Botulinum toxin treatment has recently begun to show some benefit in the control of pain from migraine and tension headache. It may also prove useful in the control of autonomic dysfunction, as in Frey syndrome, sialorrhea, and rhinorrhea. In over 20 years of use in humans, botulinum toxin has accumulated a considerable safety record, and in many cases represents relief for thousands of patients unaided by other therapy.
引用
收藏
页码:218 / 226
页数:9
相关论文
共 94 条
[1]   Botulinum toxin injection of the cricopharyngeus muscle for the treatment of dysphagia [J].
Ahsan, SF ;
Meleca, RJ ;
Dworkin, JP .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2000, 122 (05) :691-695
[2]  
Americal Academy Of Otolaryngology-head and neck surgery, 1998, PROV SECT PED TEL CA, V1
[3]   Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia [J].
Ansved, T ;
Odergren, T ;
Borg, K .
NEUROLOGY, 1997, 48 (05) :1440-1442
[4]   Botulinum toxin treatment for symptomatic Frey's syndrome [J].
Arad-Cohen, A ;
Blitzer, A .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2000, 122 (02) :237-240
[5]   Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: A report of two cases [J].
Bakheit, AMO ;
Ward, CD ;
McLellan, DL .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (02) :198-198
[6]  
Binder W., 1998, MOV DISORD, V13, P241
[7]  
Blitzer A, 1997, ARCH OTOLARYNGOL, V123, P389
[8]  
Blitzer A, 1995, OTOLARYNG HEAD NECK, V113, P668
[9]  
Blitzer A, 1997, OTOLARYNG HEAD NECK, V116, P328
[10]  
BLITZER A, 1993, ARCH OTOLARYNGOL, V119, P1018